Condition
Skin Disorder
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (5)
Early P 1 (1)
Trial Status
Completed4
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07640373Not ApplicableNot Yet Recruiting
Coping Strategies, Loneliness, and Resilience in Patients With Dermatosis
NCT07213154Not ApplicableRecruiting
Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
NCT05127044Not ApplicableCompletedPrimary
Characterization of Pre-Term Neonatal Skin
NCT05506644Not ApplicableCompleted
Biofeedback for Psoriasis
NCT05287724Early Phase 1Completed
Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli
NCT04834167Not ApplicableCompleted
OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women
Showing all 6 trials